H2 Receptor Antagonists

On this page

H2 Receptor Antagonists - Acid's Off Switch

  • Location: Gastric parietal cells, targeting H2 receptors.
  • Mechanism: Competitive antagonists of histamine; prevent histamine binding.
  • Pathway: Block histamine-induced Gs protein activation $\rightarrow$ adenylyl cyclase inhibition $\rightarrow$ ↓ cAMP levels $\rightarrow$ ↓ protein kinase A activity $\rightarrow$ reduced proton pump (H+/K+ ATPase) activation.
  • Effect: Significantly reduce gastric acid secretion, both basal (especially nocturnal) and stimulated (e.g., by food, gastrin).
  • Efficacy: Decrease total 24-hour acid output by approximately 70%.

⭐ H2 blockers are particularly effective at suppressing basal (nocturnal) acid secretion, making them useful for nocturnal heartburn.

Loading diagram…

H2 Receptor Antagonists - Tidine Titans

  • All end in "-tidine". Competitively block H2 receptors on parietal cells, ↓ acid secretion.
FeatureCimetidineRanitidineFamotidineNizatidine
Rel. Potency1x4-10x20-50x4-10x
Duration (hrs)4-66-810-126-8
Bioavailability~70%~50%~40-45%>90% (highest)
MetabolismHepatic (CYP450 inhibitor)Hepatic (minimal CYP interaction)Hepatic (minimal CYP interaction)Renal excretion (minimal metab)
Side EffectsAntiandrogenic (gynecomastia, impotence), confusion (elderly), inhibits CYP450 📌 CIMETIDINE = Cytochrome Inhibitor ManFew, well-toleratedFew, well-toleratedFew, well-tolerated

H2 Receptor Antagonists - Gut Guardians

Key Indications:

  • Peptic Ulcer Disease (PUD)
    • Gastric ulcers
    • Duodenal ulcers (Healing rates: 70-80% at 4 weeks, 85-95% at 8 weeks with cimetidine)
  • Gastroesophageal Reflux Disease (GERD)
  • Zollinger-Ellison syndrome (adjunct therapy)
  • Non-ulcer dyspepsia
  • Prevention of stress ulcers (especially in critically ill patients)

⭐ H2 blockers are generally less effective than Proton Pump Inhibitors (PPIs) for healing severe erosive esophagitis or NSAID-induced ulcers, and for rapid symptom relief in GERD.

📌 Mnemonic: "DINE with H2 Blockers" (Cimetidine, Ranitidine, Famotidine, Nizatidine - though some may be less common now).

H2 Receptor Antagonists - Side Effect Signals

  • General Side Effects:
    • Headache, dizziness
    • Diarrhea, constipation
    • Confusion (especially in elderly or renal impairment)
  • Cimetidine Specifics (📌 Cimetidine can cause 'Man-boobs, Muddled mind, and Messed-up metabolism'):
    • Antiandrogenic: Gynecomastia, galactorrhea, impotence
    • Enzyme Inhibition: Potent CYP450 inhibitor (especially CYP1A2, 2C9, 2D6, 3A4)
  • Drug Interactions (Cimetidine):
    • ↑ levels of warfarin, phenytoin, theophylline, benzodiazepines, propranolol
  • Rare Side Effects:
    • Rapid IV infusion: Bradycardia, hypotension, arrhythmias (rare)
    • Blood dyscrasias (e.g., thrombocytopenia)
  • Tolerance:
    • Pharmacodynamic tolerance can develop to acid suppression.

⭐ Tolerance to the acid-suppressing effects of H2 blockers can develop within 3 days of starting therapy, leading to ↓ efficacy with continued use.

High‑Yield Points - ⚡ Biggest Takeaways

  • H2 blockers (e.g., Cimetidine, Ranitidine, Famotidine) reversibly inhibit H2 receptors on parietal cells, ↓ acid secretion.
  • Cimetidine: Notable CYP450 inhibitor (drug interactions) and antiandrogenic effects (gynecomastia, impotence).
  • Famotidine: Most potent; Nizatidine: High bioavailability.
  • Clinical uses: Peptic ulcer disease (PUD), GERD, Zollinger-Ellison syndrome.
  • Adverse effects: Generally well-tolerated; CNS effects (confusion, dizziness) in elderly or with renal impairment.
  • Tolerance can develop with prolonged use.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: H2 Receptor Antagonists

  1. 1. Teduglutide, used in short bowel syndrome, belongs to which of the following classes?

    • A. Somatostatin analogue
    • B. GIP analogue
    • C. GLP-2 analogue
    • D. GLP-1 analogue
    Show answer

    Answer: C. GLP-2 analogue

    GLP-2 analogue is the correct class: teduglutide promotes intestinal mucosal growth, reduces epithelial apoptosis and improves absorption in short bowel syndrome. GLP-1 analogue identifies an incretin class used principally in metabolic disease, not teduglutide's class. GIP analogue identifies a different incretin pathway rather than the GLP-2 pathway. Somatostatin analogue identifies drugs that inhibit gastrointestinal secretion and are not the intestinotrophic GLP-2 replacement represented by teduglutide.

  2. 2. An adult has an uncomplicated, H. pylori-negative duodenal ulcer after NSAID use has been stopped. Which drug class is preferred for initial ulcer healing?

    • A. H2-receptor antagonists
    • B. Mucosal protectants
    • C. Prostaglandin analogues
    • D. Proton pump inhibitors
    Show answer

    Answer: D. Proton pump inhibitors

    Proton pump inhibitors are preferred because they provide potent, sustained acid suppression for ulcer healing. H2-receptor antagonists suppress acid but are generally less effective than proton pump inhibitors. Mucosal protectants can promote healing but are not the preferred initial treatment here. Prostaglandin analogues can prevent NSAID-associated ulcers but are less suitable for routine initial healing because of adverse effects such as diarrhea.

  3. 3. In an otherwise healthy adult with normal renal function receiving standard-dose oral cimetidine, which of the following adverse effects is most common among those listed?

    • A. Impotence
    • B. Confusion
    • C. Gynaecomastia
    • D. Diarrhea
    Show answer

    Answer: D. Diarrhea

    Diarrhea is the most common listed adverse effect during standard-dose oral cimetidine treatment in an otherwise healthy adult. Impotence and Gynaecomastia are less frequent antiandrogenic effects, particularly associated with higher-dose or prolonged treatment. Confusion is less likely with standard oral dosing and normal renal function; its risk increases in older patients, renal impairment and high-dose intravenous treatment.

  4. 4. Drug H is most like which of the following agents?

    • A. Norepinephrine
    • B. Phenylephrine
    • C. Epinephrine
    • D. Isoproterenol
    Show answer

    Answer: C. Epinephrine

    Epinephrine matches Drug H because the supplied table shows positive Alpha-1, Alpha-2, Beta-1 and Beta-2 activity. Norepinephrine has little clinically relevant Beta-2 activity and therefore does not match the complete profile. Phenylephrine is predominantly an Alpha-1 agonist and lacks the displayed beta activity. Isoproterenol stimulates Beta-1 and Beta-2 receptors but lacks the displayed alpha activity.

  5. 5. A patient with a previously stable INR on warfarin develops a sustained INR increase several weeks after starting one additional drug. Which drug is the most likely cause?

    • A. Amiodarone
    • B. Phenytoin
    • C. Carbamazepine
    • D. Rifampicin
    Show answer

    Answer: A. Amiodarone

    Amiodarone - Amiodarone is a well-known inhibitor of CYP2C9, the primary enzyme responsible for the metabolism of S-warfarin, the more potent enantiomer of warfarin. - Inhibition of warfarin metabolism leads to increased warfarin levels, thereby enhancing its anticoagulant effect and causing a higher INR. Phenytoin has a biphasic interaction with warfarin: INR may initially rise, whereas established enzyme induction generally lowers INR. Phenytoin is therefore not the expected cause of a sustained INR increase several weeks after initiation. Carbamazepine - Carbamazepine is a potent enzyme inducer, particularly of CYP3A4 and CYP2C9. - Like phenytoin, it generally leads to increased warfarin metabolism and a reduced INR, thereby decreasing its anticoagulant efficacy. Rifampicin - Rifampicin is a strong inducer of hepatic cytochrome P450 enzymes, especially CYP3A4 and CYP2C9. - Its co-administration with warfarin significantly increases warfarin metabolism, resulting in lower warfarin concentrations and a decreased INR.

  6. 6. An adult taking long-term ibuprofen develops an established gastric ulcer. Which drug class is preferred for ulcer healing?

    • A. H2-receptor antagonists
    • B. Antacid preparations
    • C. Proton pump inhibitors
    • D. Prostaglandin analogues
    Show answer

    Answer: C. Proton pump inhibitors

    Proton pump inhibitors - Proton pump inhibitors profoundly suppress gastric acid secretion, creating an environment that promotes ulcer healing. - They provide effective symptom relief and are the preferred treatment for drug-induced, especially NSAID-induced, peptic ulcers. H2-receptor antagonists - H2-receptor antagonists reduce gastric acid secretion but are less potent than proton pump inhibitors for healing drug-induced peptic ulcers. - They may help manage duodenal ulcer symptoms and gastroesophageal reflux, but generally provide less effective healing of NSAID-induced gastric ulcers. Antacid preparations - Antacid preparations neutralize existing gastric acid and provide immediate, temporary symptom relief. - They do not adequately address the underlying pathology or promote reliable ulcer healing, so they are not the preferred definitive treatment. Prostaglandin analogues - Prostaglandin analogues, particularly misoprostol, can prevent NSAID-induced ulcers by protecting the gastric mucosa. - Their use is limited by diarrhea and abdominal cramping, and their healing efficacy is generally inferior to proton pump inhibitors.

  7. 7. Nicotinic acid is useful in all types of hyperlipoproteinemias, EXCEPT:

    • A. Type-IV
    • B. Type-I
    • C. Type-II
    • D. Type-III
    Show answer

    Answer: B. Type-I

    Type-I - Type-I hyperlipoproteinemia results from lipoprotein lipase or ApoC-II deficiency, causing massive accumulation of dietary chylomicrons in plasma. - Niacin primarily reduces hepatic VLDL production and does not significantly improve chylomicron clearance; therefore, it is ineffective in Type-I disease. Type-IV - Type-IV hyperlipoproteinemia is characterized by elevated VLDL and triglycerides, which are reduced by niacin through inhibition of adipose hormone-sensitive lipase and hepatic VLDL production. - Because niacin lowers VLDL secretion, it is useful in Type-IV disease rather than being the exception sought in the question. Type-II - In Type-II hyperlipoproteinemia, niacin can reduce LDL by decreasing VLDL synthesis and its subsequent conversion to LDL. - This mechanism makes niacin useful in Type-IIa and Type-IIb patterns, so Type-II is not the exception. Type-III - Type-III dysbetalipoproteinemia involves accumulation of remnant particles, including IDL, and niacin can reduce their precursor VLDL. - By decreasing VLDL production, niacin may help lower remnant particles in Type-III disease; therefore, this option does not fit the exception.

  8. 8. Which of the following is a tricyclic antidepressant?

    • A. Doxepin
    • B. Fluoxetine
    • C. Citalopram
    • D. Venlafaxine
    Show answer

    Answer: A. Doxepin

    Doxepin - Doxepin is a tricyclic antidepressant (TCA) that inhibits serotonin and norepinephrine reuptake while also blocking histaminergic and cholinergic receptors. - TCAs such as doxepin are used for depression, anxiety, and certain pain conditions, consistent with the pharmacological profile of this drug class. Fluoxetine - Fluoxetine is a selective serotonin reuptake inhibitor (SSRI), not a tricyclic antidepressant, because it specifically targets serotonin reuptake. - SSRIs are commonly first-line treatments for depression because they generally have a more favorable adverse-effect profile than TCAs. Citalopram - Citalopram is an SSRI, not a tricyclic antidepressant, and primarily increases serotonergic neurotransmission by blocking serotonin reuptake. - Its classification as an SSRI distinguishes it from TCAs, which have broader receptor effects and inhibit both serotonin and norepinephrine reuptake. Venlafaxine - Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI), not a tricyclic antidepressant, despite affecting both serotonin and norepinephrine. - SNRIs have more selective reuptake effects and lack the broad receptor affinity characteristic of TCAs such as doxepin.

  9. 9. A 55-year-old woman is undergoing chemotherapy for breast cancer and experiences severe nausea and vomiting. Which antiemetic, recognized for its minimal extrapyramidal side effects, would be appropriate for her condition?

    • A. Ondansetron
    • B. Metoclopramide
    • C. Promethazine
    • D. Prochlorperazine
    Show answer

    Answer: A. Ondansetron

    Ondansetron - Ondansetron is a 5-HT3 receptor antagonist effective against chemotherapy-induced nausea and vomiting through actions on serotonin receptors in the chemoreceptor trigger zone and gastrointestinal tract. - Its favorable adverse-effect profile includes minimal extrapyramidal symptoms, making it appropriate when effective antiemesis is needed without the movement disorders associated with dopamine antagonists. Metoclopramide - Metoclopramide blocks dopamine D2 receptors and can treat nausea, with additional prokinetic effects, but it is not preferred when minimal extrapyramidal toxicity is specifically required. - Higher doses or prolonged use may cause extrapyramidal symptoms, including dystonia and tardive dyskinesia, making it less suitable than ondansetron for chemotherapy-induced vomiting in this patient. Prochlorperazine - Prochlorperazine is a phenothiazine antiemetic that primarily antagonizes dopamine receptors and can reduce nausea, but it is not the best choice when extrapyramidal effects should be minimized. - Its significant risk of acute dystonia and parkinsonism distinguishes it from ondansetron and makes it less suitable for this chemotherapy-associated presentation. Promethazine - Promethazine is a first-generation antihistamine with antiemetic activity, but it is generally less effective for chemotherapy-induced vomiting than 5-HT3 receptor antagonists. - Its prominent sedation and anticholinergic effects make it less suitable as the primary antiemetic here, despite having a lower extrapyramidal risk than dopamine antagonists.

  10. 10. Which of the following is an H2 receptor antagonist used as an anti-ulcer drug?

    • A. Pirenzepine
    • B. Famotidine
    • C. Rabeprazole
    • D. Sucralfate
    Show answer

    Answer: B. Famotidine

    Famotidine - Famotidine is a potent, selective H2 receptor antagonist that blocks histamine receptors on gastric parietal cells and reduces acid secretion. - It is used to treat peptic ulcers, gastroesophageal reflux disease, and other acid-related disorders, making it the correct choice. Sucralfate - Sucralfate is a cytoprotective agent that forms an adherent protective gel over ulcerated mucosa, shielding it from acid, pepsin, and bile. - It does not directly block H2 receptors or reduce acid secretion; its anti-ulcer effect is primarily through mucosal protection. Pirenzepine - Pirenzepine is a relatively selective M1 muscarinic antagonist that reduces cholinergic stimulation of gastric acid secretion. - Although it has been used as an anti-ulcer drug, its mechanism differs from H2 receptor antagonism, so it is not the best answer. Rabeprazole - Rabeprazole is a proton pump inhibitor that irreversibly blocks the H+/K+-ATPase in gastric parietal cells, producing profound acid suppression. - Its target is the proton pump, not the histamine H2 receptor, distinguishing it from H2 receptor antagonists.

Flashcards: H2 Receptor Antagonists

  1. 1. Drug of choice for prevention of NSAID induced peptic ulcer disease is

    Show answer

    Proton Pump Inhibitors (PPIs)

  2. 2. Histamine binds to _____ receptors on parietal cells, causing _____ H+ secretion

    Show answer

    H2 · increased

  3. 3. The most effective therapy for NSAID-induced ulcer is

    Show answer

    proton pump inhibitors.

  4. 4. The H2 receptor antagonist _____ is a potent _____ of _____ and therefore has multiple drug interactions

    Show answer

    cimetidine · inhibitor · cytochrome P-450

  5. 5. Side effects of metoclopramide include _____ and _____ as a result of central D2 blockade

    Show answer

    drowsiness · depression

  6. 6. H2 receptor antagonists are especially effective at reducing _____ secretion of acid, however, they only have modest impact on _____-stimulated secretion of acid

    Show answer

    nocturnal · meal

  7. 7. Bile acid resins can lead to _____, which may impair the absorption of _____

    Show answer

    steatorrhea · fat-soluble vitamins (A, D, E, K)

  8. 8. _____ is _____ receptor antagonist used in treatment of _____

    Show answer

    Netazepide · CCK-B · gastrinoma/Zollinger-Ellison Syndrome

  9. 9. _____ is a gastroprokinetic agent which acts as a _____ receptor agonist

    Show answer

    Cisapride · 5-HT4

  10. 10. _____ (macrolide) can bind GI _____, increasing GI motility and causing diarrhea

    Show answer

    Erythromycin · motilin receptors

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF